INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 28, 2015 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Bona fide gift | 1,000 | -- | 16,405 |
| Apr 01, 2015 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Bona fide gift | 462 | -- | 154,804 |
| Jan 06, 2015 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Bona fide gift | 511 | -- | 155,266 |
| Dec 16, 2014 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 3,264 | -- | 500,000 |
| Dec 16, 2014 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 3,264 | -- | 569,588 |
| Nov 24, 2014 |
Director
Trans History: 466
|
Director | Form 4 | Bona fide gift | 2,000 | -- | 18,349 |
| Nov 18, 2014 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Bona fide gift | 250 | -- | 18,584 |
| Nov 17, 2014 |
SVP Administration & Asst Secr
Trans History: 645
|
SVP Administration & Asst Secr | Form 4 | Bona fide gift | 1,930 | -- | 61,172 |
| Nov 17, 2014 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Bona fide gift | 24,900 | -- | 369,093 |
| Nov 14, 2014 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 2,313 | -- | 566,324 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.